You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

axonal remyelination

Showing 1 - 25 of 202
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Imaging Interplay Between Axonal Damage and Repair in Multiple

Recruiting
  • Multiple Sclerosis (MS)
  • +3 more
  • MRI
  • +2 more
  • Basel, Switzerland
    University Hospital Basel, Department of Neurology
Dec 15, 2021

Multiple Sclerosis Trial in Pavia (18F-florbetaben PET/CT)

Recruiting
  • Multiple Sclerosis
  • 18F-florbetaben PET/CT
  • Pavia, PV, Italy
    ICS Maugeri SpA SB IRCCS
Mar 23, 2023

Multiple Sclerosis, Sclerosis, Demyelinating Diseases Trial in Portland (Aerobic exercise, Education Group Control)

Recruiting
  • Multiple Sclerosis
  • +6 more
  • Aerobic exercise
  • Education Group Control
  • Portland, Oregon
    Oregon Health & Science University
Aug 8, 2022

Relapsing Remitting Multiple Sclerosis, Optic Neuropathy, Optic; Neuritis, With Demyelination Trial in Australia, Canada, United

Terminated
  • Relapsing Remitting Multiple Sclerosis
  • +2 more
  • Dallas, Texas
  • +6 more
Aug 10, 2022

Macrophages Activation Pattern in X-linked Adrenoleukodystrophy,

Recruiting
  • Adrenoleukodystrophy
  • +3 more
  • Blood sample collection
  • Le Kremlin-Bicêtre, France
  • +1 more
Oct 10, 2022

Optic Neuritis Trial in Nanning (Edaravone)

Recruiting
  • Optic Neuritis
  • Nanning, China
    Yi Du
Sep 13, 2022

Gray Matter Demyelination in Primary Progressive MS at 7T

Recruiting
  • Primary Progressive Multiple Sclerosis
    • Hvidovre, Denmark
      Danish Research Centre for Magnetic Resonance
    Jun 5, 2022

    Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting Trial in San Francisco (Bazedoxifene Acetate)

    Recruiting
    • Multiple Sclerosis
    • Multiple Sclerosis, Relapsing-Remitting
    • Bazedoxifene Acetate
    • San Francisco, California
      Weill Institute for Neurosciences, University of California, San
    Mar 21, 2022

    Demyelinating Diseases, Demyelination; Corpus Callosum, Multiple Sclerosis Brain Lesion Trial in San Francisco (Clemastine

    Not yet recruiting
    • Demyelinating Diseases
    • +4 more
    • Clemastine Fumarate
    • Placebo
    • San Francisco, California
      Sandler Neurosciences Building, Neurological Clinical Research U
    Oct 3, 2023

    Multiple Sclerosis (MS), Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Primary Progressive Trial in San Francisco

    Not yet recruiting
    • Multiple Sclerosis (MS)
    • +6 more
    • Clemastine Fumarate
    • Placebo
    • San Francisco, California
      Sandler Neurosciences Building, Neurological Clinical Research U
    Jan 23, 2023

    Multiple Sclerosis, Relapsing-Remitting Trial in Porto Alegre (Cladribine 10 mg oral tablet)

    Active, not recruiting
    • Multiple Sclerosis, Relapsing-Remitting
    • Cladribine 10 mg oral tablet
    • Porto Alegre, RS, Brazil
      Pontifical Catholic University of Rio Grande do Sul
    Jun 5, 2023

    Multiple Sclerosis Trial in New York (Adrenocorticotropic hormone (ACTH) gel (H.P. Acthar®))

    Terminated
    Has Results
    • Multiple Sclerosis
    • Adrenocorticotropic hormone (ACTH) gel (H.P. Acthar®)
    • New York, New York
      Weill Cornell Medicine
    Dec 31, 2020

    Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Secondary-progressive Multiple Sclerosis Trial in Belgium (Metformin

    Not yet recruiting
    • Multiple Sclerosis
    • +2 more
    • Metformin Hydrochloride 850 mg Oral Tablet
    • Placebo
    • Brugge, Belgium
    • +4 more
    May 30, 2023

    Parkinson's Disease and Parkinsonism Trial (DBS)

    Not yet recruiting
    • Parkinson's Disease and Parkinsonism
    • DBS
    • (no location specified)
    Jun 28, 2023

    Multiple Sclerosis Trial (imaging of energy dysfunction)

    Not yet recruiting
    • Multiple Sclerosis
    • imaging of energy dysfunction
    • (no location specified)
    Aug 26, 2020

    Back Pain Trial (Pilates Exercise, Mckenzie Exercise)

    Not yet recruiting
    • Back Pain
    • Pilates Exercise
    • Mckenzie Exercise
    • (no location specified)
    Jun 1, 2023

    Multiple Sclerosis, Inflammatory Disease Trial (PET-MRI with [18F]-Florbetaben and PET-MRI with [18F]-DPA-714)

    Not yet recruiting
    • Multiple Sclerosis
    • Inflammatory Disease
    • PET-MRI with [18F]-Florbetaben and PET-MRI with [18F]-DPA-714
    • (no location specified)
    Jan 10, 2022

    Multimodal Imaging Signatures of Biological Mechanisms

    Not yet recruiting
    • Multiple Sclerosis (MS)
    • MRI
    • (no location specified)
    Jan 12, 2023

    Neurodegenerative Process Within Visual Ways In Multiple

    Completed
    • Multiple Sclerosis
      • Lille, France
        Hôpital Roger Salengro, CHRU
      Sep 20, 2022

      Gender Dysphoria Trial in Nashville (Polyethylene Glycol 3350)

      Recruiting
      • Gender Dysphoria
      • Polyethylene Glycol 3350
      • Nashville, Tennessee
        Vanderbilt University Medical Center
      Jun 1, 2023

      Polyneuropathy, Amyloidosis Trial in Jette (ECG + echocardiography, Answering questionnaires)

      Recruiting
      • Polyneuropathy
      • Amyloidosis
      • ECG + echocardiography
      • Answering questionnaires
      • Jette, Belgium Capital City, Belgium
        UZ Brussel
      Jul 14, 2023

      Spinal Cord Gray Matter Imaging in Spinal Muscular Atrophy

      Enrolling by invitation
      • Spinal Muscular Atrophy Type III
      • Spinal Muscular Atrophy Type II
      • MRI
      • Basel, BS, Switzerland
        University Hospital Basel
      Nov 15, 2023

      Optic Neuritis Trial in San Francisco (Clemastine, Placebo)

      Recruiting
      • Optic Neuritis
      • San Francisco, California
        University of California San Francisco
      Jan 5, 2023

      Chronic Pain, Opioid Use, and Epidermal Nerve Fiber Density

      Recruiting
      • Chronic Pain
      • +2 more
        • Kansas City, Kansas
          University of Kansas Health System
        Jun 14, 2022

        Multiple Sclerosis Trial in Cambridge (Metformin and clemastine in combination, Placebo)

        Recruiting
        • Multiple Sclerosis
        • Metformin and clemastine in combination
        • Placebo
        • Cambridge, United Kingdom
          Addenbrooke's Hospital
        Jun 14, 2022